Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| P30CA046934 | U.S. NIH Grant/Contract | View source | |
| NCI-2021-08865 | Other Identifier | CTRP |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
| Institute of Cannabis Research | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
To determine how daily cannabis use affects surgical outcomes.
To determine if patients who are daily cannabis users that are undergoing inpatient abdominal surgery for the treatment of cancer are different from non-cannabis users regarding phytocannabinoid and endocannabinoid levels, pain scores, pain medication requirements, and surgical complications.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Daily cannabis users | Patients undergoing inpatient abdominal surgery for the treatment of cancer who self-report daily cannabis use | ||
| Cannabis non-users | Patients undergoing inpatient abdominal surgery for the treatment of cancer who self-report no cannabis use |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative opioid consumption | Postoperative opioid consumption among daily cannabis using and non-cannabis using patients undergoing abdominal surgery for cancer | 30 days |
| Correlation of postoperative opioid consumption | Correlation between serum phytocannabinoid and endocannabinoid levels, pain scores, and postoperative opioid consumption | 30 days |
| Correlation of postoperative complications | Correlation between 30-day post-operative complications, preoperative, and postoperative phytocannabinoid and endocannabinoid levels | 30 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Cancer patients over the age of 18 undergoing inpatient abdominal surgery for the treatment of cancer who use cannabis daily prior to surgery or who are non-users of cannabis.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ana Gleisner | University of Colorado, Denver | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Colorado Hospital | Denver | Colorado | 80045 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| D009369 | Neoplasms |
| D002189 | Marijuana Abuse |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
Not provided
Not provided
Not provided
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |